Slide 1: August 2023 Investor Presentation
August 2023 Investor Presentation Nasdaq: ISPC The Online Marketplace for Human Biospecimens Transforming Biospecimen Procurement
Slide 2: Forward-looking statements
This presentation may contain forward - looking statements within the meaning of Section 27 A of the Securities Act of 1933 , as amended, and Section 21 E of the Securities Exchange Act of 1934 , as amended . Such forward - looking statements are characterized by future or conditional verbs such as
Slide 3: Our Vision
Our Vision To transform the biospecimen industry with an online marketplace connecting researchers to patients, biospecimens, and data, through our global network. 3
Slide 4: Investor Highlights
4 1. Similar to Amazon, iSpecimen has developed an online marketplace to seamlessly connect researchers with healthcare providers and supplier organizations 2. First mover advantage that addresses an inefficient and fragmented global biospecimen supply chain that is poised to be disrupted by an onli
Slide 5: Biospecimens are Essential for Life Science R&D
Biospecimens are Essential for Life Science R&D Basic Research Biomarker Identification & Validation Drug Discovery & Development Diagnostics Discovery & Validation Biofluids Solid Tissue Stem & Immune Cells Plasma, Serum, Urine, Saliva Industry Academia Government 5 Lung, Breast, Colon, Brain Bone
Slide 6: Biospecimen Supply Chain Challenges
Biospecimen Supply Chain Challenges Providers miss revenue and research opportunities > 3 Billion clinical specimens are discarded annually worldwide 5 > 1 Billion Patient encounters yearly in the U.S. where a specimen could be provided for research 4 > 800 Million banked specimens are in bioreposit
Slide 7: Biospecimen Supply Chain Challenges - Difficult to Connect, Search and Transact
Biospecimen Supply Chain Challenges 7 - Difficult to Connect, Search and Compliantly Transact - Average time to develop relationships is 6 - 12 months ᶟ 3 “Sources Cited” page 28 PROVIDERS RESEARCHERS CHALLENGE
Slide 8: The iSpecimen Marketplace Solution
The iSpecimen Marketplace Solution 8 - iSpecimen Customer Base: 70% of the Top 20 Pharma Companies and IVD Companies Worldwide PROVIDERS RESEARCHERS SOLUTION
Slide 9: Full-Service Procurement Offering
Full - Service Procurement Offering - Connect Suppliers with Researchers - Manage the Entire Procurement Process SPECIMEN SEARCH & SELECTION SPECIMEN LOGISTICS SPECIMEN MANAGEMENT DATA MANAGEMENT STUDY/ORDER MANAGEMENT SUPPLIER SITE TRAINING COLLECTION KIT BUILDING COMPLIANCE MANAGEMENT STUDY DESIGN
Slide 10: iSpecimen Value Proposition
Advance Scientific Discovery Support research mission and advance diagnostic, therapeutic and vaccine research Monetize Banked Biospecimens Instantly connect to a global network of researchers in search for biospecimens Ensure Compliance Protect the privacy and security of patient information Accele
Slide 11: Global Footprint
Global Footprint United States Dominican Republic United Kingdom Jamaica Germany Spain France Mexico Ukraine Netherlands Georgia Venezuela Bulgaria Turkey Russian Federation Romania India Armenia Peru 11 Agreements with 200+ Supplier Organizations ✔ 1,000+ Hospitals ✔ 1,000s of Clinics and Practice
Slide 12: Strategic Growth Initiatives
Strategic Growth Initiatives 12
Slide 13: Enhance iSpecimen Marketplace Technology
Enhance iSpecimen Marketplace Technology 13 Increased investment and ongoing advancements of iSpecimen Marketplace technology: ● Improve integration with provider partners (first patient data electronic record integrations) ● Improve iSpecimen Marketplace search and request capabilities ● Update bac
Slide 14: 2023–2025 iSpecimen Product Roadmap
2023 – 2025 iSpecimen Product Roadmap 2023 Revamp Customer Search Experience, Unify data, and Automate Matchmaking 2024 Enhance Supplier Experience though enablement, reporting and workflow. Expand Prospective search capabilities 2025 Continue to evolve Efficiencies, Matchmaking and Data. iSpecimen
Slide 15: Revenue Enhancement Opportunities
Revenue Enhancement Opportunities 15 ● Sequencing ○ We believe iSpecimen will be the first company in industry to offer on - demand sequenced cancer specimens for research on a large scale, utilizing our extensive supplier network and leveraging the Marketplace platform. ○ Successfully launched firs
Slide 16: Capitalize on Growing Data Asset
“Utilization of sample data for research and for monetization is the next key value driver for the biobanks.” - Frost & Sullivan, Global Biobanking Market Landscape Capitalize on Growing Data Asset Banked Specimen Records Patient Records Medical Condition Records Clinical Specimen Records Laboratory
Slide 17: Financial Overview
Financial Overview 17
Slide 18: Annual Revenue 2015 – Q2 2023
$700 $1,448 $3,067 $4,395 $4,298 $8,184 $11,135 $10,402 $4,575 2015 2016 2017 2018 2019 2020 2021 2022 1H23 Annual Revenue ($000) 2015 – Q2 2023 (Unaudited) ▲ 48% CAGR Revenue (2015 – 2022) Annual Revenue 18
Slide 19: Statement of Operations
Statement of Operations Revenue Operating expense: Cost of revenue Technology Sales and marketing Supply development Fulfillment General and administrative Total operating expenses Loss from operations Other expense, net Interest expense Other income (expense), net Interest income Total other income
Slide 20: Balance Sheet
Balance Sheet 20 Note: As of June 30, 2013, Cash + Investments – Short Term = $8,213,991 2
Slide 21: Common Stock Information
Common Stock Information iSpecimen Inc. Fully Diluted Shares Outstanding Shares outstanding at June 30, 2023 Shares issuable upon vesting of RSUs Shares issuable upon exercise of stock options Shares issuable upon exercise of warrants to purchase common stock Total diluted shares at June 30, 2023 @i
Slide 22: Tracy Curley, Chief Executive Officer, Chief Financial Officer and Treasurer
Tracy Curley | Chief Executive Officer, Chief Financial Officer and Treasurer Ms . Curley brings three decades of experience in public accounting and corporate finance for both publicly traded companies and emerging companies like iSpecimen and joined iSpecimen in August 2020 . She came to iSpecimen
Slide 23: Investor Highlights
2 3 1. Similar to Amazon, iSpecimen has developed an online marketplace to seamlessly connect researchers with healthcare providers and supplier organizations 2. First mover advantage that addresses an inefficient and fragmented global biospecimen supply chain that is poised to be disrupted by an on
Slide 24: Contact us
Sign up for a free iSpecimen Marketplace account at iSpecimen.com Contact us. iSpecimen Inc. 450 Bedford Street Lexington, MA 02420 investors@ispecimen.com Be a part of the biospecimen revolution
Slide 25: Appendix
Appendix 25
Slide 26: Strategic Evolution
PHASE 3 Expansion via the Online iSpecimen Marketplace Œ START UP Company Ideation and Self - Funding PHASE 1 Proof of Concept PHASE 2 Critical Mass of Suppliers and Early Customer Adoption �� � 2010 – 2011 2012 – 2013 2014 – 2017 2018 – 2022 0 Customers 1 Supplier Agreement 0 Specimen Records 0 Pat
Slide 27: iSpecimen Marketplace UI/UX
iSpecimen Marketplace UI/UX Click Search to start searching for specimens 27
Slide 28: iSpecimen Marketplace UI/UX
2 8 iSpecimen Marketplace UI/UX Use search bar to quickly find specimens that match search criteria
Slide 29: Refine Search Results Using Sliders and Check Boxes
Refine Search Results Using Sliders and Check Boxes iSpecimen Marketplace UI/UX 29
Slide 30: View Quote Request and Add More Specimens
View Quote Request and Add More Specimens Request a Quote iSpecimen Marketplace UI/UX 30 Track and Manage Requests
Slide 31: Sources Cited
31 Page Note Source Cited 7 1 iSpecimen estimates based on In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product, By Application, By Technology (Immunochemistry, Molecular Diagnostics) By End - use, By Region, And Segment Forecasts, 2021 – 2027. Grandview Research, January 2021
Slide 32: iSpecimen Marketplace
@ iSPECIMEN Marketplace’